Skip to Main Content

Author Details

Kevin Holcomb
Weill Cornell Medical College
1996
130
26
PMIDPaper TitleJournal TitlePublished Year
36376567Landmark Series on Disparities: Uterine Cancer and Strategies for Mitigation.Ann Surg Oncol2023
37651980Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.Gynecol Oncol2023
37788366Patient and provider perspectives on telemedicine use in an outpatient gynecologic clinic serving a diverse, low-income population.J Telemed Telecare2023
37934933Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis.JCO Clin Cancer Inform2023
37214514Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis.PEC Innov2023
37415958Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population.Gynecol Oncol Rep2023
37116391Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.Gynecol Oncol2023
37062188Web-based tool for cancer family history collection: A prospective randomized controlled trial.Gynecol Oncol2023
36074132Understanding Perceived Barriers to Colposcopy Follow-Up Among Underserved Women at an Urban Teaching Hospital: A Qualitative Study.J Low Genit Tract Dis2023
36207653Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?Fam Cancer2023
36348204Expanding Medicaid Improves Outcomes in Gynecologic Malignancies, But is it Enough?Ann Surg Oncol2023
34483300Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.Int J Gynecol Pathol2022
35548047Corrigendum: The Potential Distribution of <i>Pythium insidiosum</i> in the Chincoteague National Wildlife Refuge, Virginia.Front Vet Sci2022
35552618Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer.Cancer Discov2022
36001346Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy.Cancer Prev Res (Phila)2022
36305018What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.Cancer2022
35960887Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.J Clin Oncol2022
35242980Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting.Gynecol Oncol Rep2022
32720237Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.J Gen Intern Med2021
33681336The Potential Distribution of <i>Pythium insidiosum</i> in the Chincoteague National Wildlife Refuge, Virginia.Front Vet Sci2021
33710136Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.Am J Clin Oncol2021
33899220Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID-19 pandemic among low-income women in New York City.Cancer2021
34381847Sex-Related Differences in Clinical Presentation and Risk Factors for Mortality in Patients Hospitalized With Coronavirus Disease 2019 in New York City.Open Forum Infect Dis2021
34328789Leveraging Health Information Technology to Collect Family Cancer History: A Systematic Review and Meta-Analysis.JCO Clin Cancer Inform2021
34286887Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.Oncologist2021
34023131Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.Gynecol Oncol2021
34355345Mental Health of US Medical Students During the COVID-19 Pandemic.J Gen Intern Med2021
33166660A Perspective on James Marion Sims, MD, and Antiblack Racism in Obstetrics and Gynecology.J Minim Invasive Gynecol2021
33308865Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic.Gynecol Oncol2021
33074900Perioperative Morbidity and Mortality of Patients With COVID-19 Who Undergo Urgent and Emergent Surgical Procedures.Ann Surg2021
31633516Disparities in the Use of Adjuvant External Beam Radiation Therapy in Node-positive Cervical Cancer Patients Following Hysterectomy.Am J Clin Oncol2020
31959493Primary malignant ovarian carcinoid; management and outcomes.Gynecol Oncol2020
31922918Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.J Clin Oncol2020
33204795Treatment patterns and outcomes among women with brain metastases from gynecologic malignancies.Gynecol Oncol Rep2020
32839026State of the science: Uterine sarcomas: From pathology to practice.Gynecol Oncol2020
32598911Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer.Am J Obstet Gynecol2020
32847998Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature.Int J Gynecol Cancer2020
32981694Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals.Gynecol Oncol2020
32582376Clinicopathologic features of endometrial cancer with mismatch repair deficiency.Ecancermedicalscience2020
32448806Is hysterectomy necessary for the treatment of preinvasive stratified mucin producing intraepithelial lesions of the cervix?Int J Gynecol Cancer2020
32276935Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix.Int J Gynecol Cancer2020
32256692Multiple malignant transformations of an ovarian mature cystic teratoma.Ecancermedicalscience2020
32565896Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management.Ecancermedicalscience2020
31299359Inferior Mesenteric Arterial Supply to a Symptomatic Uterine Myoma.J Minim Invasive Gynecol2020
30700566Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors.Int J Gynecol Cancer2019
29890352Minimally Invasive Staging of Apparent Stage I Malignant Ovarian Germ Cell Tumors: Prevalence and Outcomes.J Minim Invasive Gynecol2019
31557556Incidence of isolated para-aortic lymph node metastasis in early stage endometrial cancer.Eur J Obstet Gynecol Reprod Biol2019
31396597Evaluation of lysophosphatidic acid in vaginal fluid as a biomarker for ovarian cancer: A pilot study.Eur J Obstet Gynecol Reprod Biol X2019
31592503Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.JCO Precis Oncol2019
31305485Clinical Controversies in Cervical Cancer Screening.Clin Obstet Gynecol2019
  • 1 - 50 of 130

Recommended Authors

Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 0
Uniformed Services of the Health Sciences Gynecologic Cancer Center of Excellence
Career Start Year 2007
Number of shared co-authors 1
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 0
Eberhard Karls University Tubingen
Career Start Year 2005
Number of shared co-authors 1
Westmead Hospital
Career Start Year 2003
Number of shared co-authors 1
University Hospital
Career Start Year 2002
Number of shared co-authors 2
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 0
University of Toronto.
Career Start Year 2001
Number of shared co-authors 2
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 1
University of Southern California
Career Start Year 1995
Number of shared co-authors 1
Westmead Hospital
Career Start Year 1995
Number of shared co-authors 0
John A. Burns School of Medicine, University of Hawaii
Career Start Year 1995
Number of shared co-authors 2
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 0
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 0
Barts Health NHS Trust
Career Start Year 1993
Number of shared co-authors 1
University of Glasgow
Career Start Year 1992
Number of shared co-authors 2
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Avenue
Career Start Year 1990
Number of shared co-authors 2
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 1
Clinica Quirurgica 2 (Surgical Clinic 2), Hospital Maciel
Career Start Year 1990
Number of shared co-authors 3
Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 1989
Number of shared co-authors 2
University of British Columbia
Career Start Year 1987
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1987
Number of shared co-authors 4
Mayo Clinic
Career Start Year 1984
Number of shared co-authors 1
Duke School of Medicine
Career Start Year 1983
Number of shared co-authors 3
David Geffen School of Medicine, University of California los angeles
Career Start Year 1981
Number of shared co-authors 5

Collaborators

Weill Cornell Medical College
Co-authored papers 52
Emory University School of Medicine
Co-authored papers 12
Weill Cornell Medical College
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Meyer Cancer Center
Co-authored papers 4
Institute for Computational Biomedicine
Co-authored papers 4
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 4
Weill Cornell Medical Center
Co-authored papers 3
Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine
Co-authored papers 3
Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health
Co-authored papers 3
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 3
New York-Presbyterian Hospital, Weill Cornell Medical Center
Co-authored papers 2
New York Presbyterian Hospital/Weill Cornell Medical Center
Co-authored papers 2
Co-authored papers 2
Englander Institute for Precision Medicine
Co-authored papers 2
Dartmouth-Hitchcock Medical Center
Co-authored papers 2
Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine
Co-authored papers 2
Weill Cornell Medical Center
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 2
Weill Cornell University
Co-authored papers 2
Loma Linda University
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 2
Sandra and Edward Meyer Cancer Center
Co-authored papers 2
The Wistar Institute
Co-authored papers 2
New York-Presbyterian Hospital-Weill Cornell Medical College
Co-authored papers 2
Case Western Reserve University
Co-authored papers 2
Sandra and Edward Meyer Cancer Center
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 2